Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 37(6); 2005 > Article
Review Article The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis
Eun-Kyoung Yim, Ph.D., Jong-Sup Park, M.D., Ph.D.
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2005;37(6):319-324.
DOI: https://doi.org/10.4143/crt.2005.37.6.319
Published online: December 31, 2005

Department of Obstetrics and Gynecology, The Catholic University of Korea College of Medicine, Seoul, Korea.

Correspondence: Jong-Sup Park, Department of Obstetrics and Gynecology, The Catholic University of Korea College of Medicine, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Korea. (Tel) 82-2-590-2596, (Fax) 82-2-595-8774, jspark@catholic.ac.kr

Copyright © 2005 Korean Cancer Association

  • 23,523 Views
  • 478 Download
  • 263 Crossref
next
  • Cervical cancer is one of the leading world causes of cancer morbidity and mortality in woman, with more than 98% related to a human papillomavirus (HPV) infection origin. Infection with specific subtypes of HPV has been strongly implicated in cervical carcinogenesis. The identification and functional verification of host proteins associated with HPV E6 and E7 oncoproteins may provide useful information in understanding cervical carcinogenesis and the development of cervical cancer-specific markers. The advent of functional genomics and proteomics has provided hope of discovering novel biological markers for use in the screening, early diagnosis, prognostication and prediction of response to therapy. Herein, we review the studies where the profiles of host proteins associated with HPV E6 and E7 oncoproteins in cervical cancer were generated.
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection in the world, occurring at some point in up to 75% of sexually active women. Although HPV infection is widespread, few people even know they are infected as the symptoms are seldom noticeable. It is even less well known that nearly all cervical cancers (99.7%) are directly linked to previous infection with one or more of the oncogenic types of HPV (1). It is estimated that for every 1 million women infected, 10% (about 100,000) will develop precancerous changes in their cervical tissue. Of these, about 8% will develop early cancer limited to the whole epithelial layer of the uterine cervix (carcinoma in situ; CIS), and a few will develop invasive cancer unless the precancerous lesions are detected and treated, with such cases having been found to carry the oncogenic HPVs (e.g., types 16 and 18) that cause cervical cancer. HPVs have circular, double-stranded DNA genomes that are approximately 8 kb in size and encode eight genes, of which E6 and E7 have transforming properties. These proteins have pleiotropic functions, such as transmembrane signaling, regulation of the cell cycle, transformation of established cell lines, immortalization of primary cell line and regulation of chromosomal stability. The viral E6 and E7 oncoproteins are necessary for malignant conversion. The abilities of high-risk HPV E6 and E7 proteins to associate with the tumor suppressors p53 and pRB, respectively, have been suggested as a mechanism by which these viral proteins induce tumors (Fig. 1). The E6 protein consists of 158 amino acid residues and contains two zinc-finger binding motifs (2). The E6 protein is thought to promote cell proliferation by stimulating degradation of the tumor suppressor p53 protein via the formation of a trimeric complex comprising E6, p53 and the cellular ubiquitination enzyme E6-AP. E6-stimulated degradation interferes with such biological functions of p53; thus perturbing the control of cell cycle progression, leading finally to increased tumor cell growth (3). Although it is commonly accepted that the ability of high-risk type HPV E6 to target p53 for degradation contributes to virus-induced cellular transformation, it is also clear that the E6 protein has oncogenic activities that are independent of p53.
The E7 proteins encoded by the high-risk type HPVs, such as HPV 16 and HPV 18, bind Rb with a much higher affinity compared to those encoded by the low-risk type HPVs, such as HPV 6 and HPV 11. E7 binds to a region of the Rb protein commonly referred to as the 'pocket domains' (4). The 'pocket domain' sequences of Rb are essential for its tumor suppressor function, with many naturally occurring loss-of-function mutations of Rb appearing to cluster in these 'pocket domains'. One of the major biochemical functions of Rb is to bind E2F-family transcription factors and repress the expressions of replication enzyme genes (5). The ability to repress the expressions of replication enzyme genes correlates with the tumor suppression function of Rb. E7 disrupts the interaction between Rb and E2F, resulting in the release of E2F factors in their transcriptionally active forms (6). This E7-mediated conversion of E2Fs to their activator forms stimulates replication and cell-division, which is consistent with the observation that keratinocytes constitutively expressing E7 remain replication- competent, even after differentiation (7). Therefore, complex formation between the products of oncogenes and tumor suppressor genes is believed to be important in the cellular transformation that leads to the disruption of the normal physiological functions of the specific tumor suppressor gene products.
Cervical cancer-specific biomarkers, as yet, have not been well characterized. The diagnosis of cervical cancer is based on histological examinations, with the prognosis assessed based on the clinical features, such as the stage of the disease at diagnosis. Host proteins associated with HPV E6 and E7 oncoproteins should contain fundamental information about the development and progression of HPV-associated cervical carcinogenesis. Utilization of this information for discovering biomarkers, and/or therapeutic targets could be possible if a tool can be developed to rapidly analyze and display changes in protein expression under different conditions for neoplastic cell subpopulations. Therefore, the search for proteins associated with a given cancer is a major challenge.
The E6 oncoproteins of high risk HPV interfere with the function of the cellular tumor-suppressor protein p53 through the induction of increased proteasome-dependent p53 degradation. High risk HPV E6 proteins target the cellular E3 ubiquitin ligase E6AP to p53, resulting in the transfer of ubiquitin peptides from E6AP to p53, which marks p53 for degradation by the 26S proteasome. Low risk and cutaneous epithelia-infecting HPV E6 proteins are unable to target the cellular p53 protein for degradation through the proteasome pathway. Although E6-induced loss of p53 is an important element of E6-induced cellular transformation, recent studies have identified a number of additional cellular targets of E6 that may also play an important role. These included the following (8, 9): proteins involved in the regulation of transcription and DNA replication, such as p300/CBP, Gps2, IRF-3, hMcm7, E6TP1 and ADA3; proteins, involved in apoptosis and immune evasion, such as Bak, TNF receptor 1 (TNF R1), FADD and c-Myc,; proteins involved with epithelial organization and differentiation, such as paxillin, E6BP/ERC-55, zyxin and fibulin-1; proteins involved in cell-cell adhesion, polarity and proliferation control, which contain a PDZ-binding motif, such as hDLG, hScrib, PKN, MAGI-1, MAGI-2, MAGI-3 or MUPP1; and proteins involved in DNA repair, such as XRCC1 and 6-O-methylguanine-DNA methyltransferase (MGMT) (Table 1).
In this article, we described the global pattern of protein expression in human adenocarcinoma cell lines stably expressing HPV E6 gene, compared with those of control cells, using a proteomics analysis. An interesting study in comparative proteomics showed the expression of proteins in response to transfection by E6. The prominent function of HPV E6 is the proteolytic inactivation of certain pro-apoptotic factors, such as p53, Bak or Bax, through the ubiquitin-proteasome pathway (10, 11). The Bcl-2 family of proteins is a critical death regulator of mitochondrial integrity and of mitochondria-initiated apoptosis. Bak plays a major role in the apoptosis of several types of cells. The findings of increased levels of Bcl-2 and decreased Bak expression indicates a change in the balance of anti-apoptotic and pro-apoptotic molecules, with a shift in favor of the former. Although Bcl-2 appears to bind poorly to Bak, the over-expression of Bcl-2 is shown to suppress the death function of Bak (12). Therefore, the imbalance between Bcl-2 and Bak is believed to play a role in promoting growth in E6-infected cells. TRAF-interacting protein (I-TRAF) has been shown to be up-regulated by E6. I-TRAF, a novel signal transducer of the TNFR superfamily, inhibits the induction of NF-κB activation mediated by TNFR6, which indirectly interacts with TRAF2 via TRADD. However, I-TRAF was unable to inhibit the activation of NF-κB by IL-1R, which is mediated by TRAF6 (13), suggesting a negative effect of I-TRAF on NF-κB activation was specific to a TRAF2- mediated pathway. E6 may suppress the function of I-TRAF as a negative regulator of NF-κB activation. Cellular damage or stress results from two fundamental cellular responses: apoptosis, a precisely programmed form of cell death, and stress response, or the expression of heat shock protein (HSP), which protects cells and mediates an accelerated recovery following damage. HSPs are multi functional molecular chaperons relating to cellular homeostasis. Primary, HSPs are expressed in response to cellular stresses, which may also include carcinogenesis. E6 induced stronger up-regulation of HSP60, HSP70 and HSP90-β proteins in our experiment. There has been a report that the expressions of HSP40, HSP60 and HSP70, but not that of HSP90, were increased with increasing severity of the cervical lesion, suggestive of stress responses from the progression from an HPV infection to cervical cancer.
Many proteins involved in cell cycle progression are expressed, including E2F5 and CDK5 (cyclin-dependent kinase5). Proteins involved in G1/S progression are decreased, and were thought to be concerned with cyclin-dependent kinase regulation. Transformed cells expressing E6 lose the G1 checkpoint activity at a very early point, presumably due to the degradation of p53. The G2 checkpoint is initially unaffected, but there is increased chromosomal instability in E6-expressing cells over time, which is probably caused by the observed attenuation of the G2 checkpoint function (14). This may be caused by E6 altering the cyclin/cdk complexes, or may relate to the ablation of a p53-regulated G2/M checkpoint. The up- regulated proteins have been studied further for their diagnostic potential.
In our previous work, we looked for p53-independent HPV E6 interacting proteins, using a yeast two-hybrid screening, which resulted in the identification of p73; a homologue protein of p53. The functional inactivation of p73, by both high- and low-risk HPV E6, could play an important role in the malignant transformation and benign condyloma formation of the cervix (15).
Recently, we found a novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1), which was described as a crucial partner of the breast and ovarian tumor suppressor BRCA1 (16). We also demonstrated the existence of BARD1 as a p53 tumor co-suppressor, which inactivated the E6 oncoprotein.
HPV E7 proteins interact with the so-called 'pRb-associated pocket proteins', including the retinoblastoma protein pRb, which are negative cell-cycle regulators involved in the G1/S and G2/M transitions. The interaction between high-risk E7 and pRb results in enhanced phosphorylation and degradation. pRb destruction leads to the release of E2F family of transcription factors and the subsequent activation of genes promoting cell proliferation. However, the stimulatory effect of E7 upon cell proliferation not only depends on its association with pRb, since E7 targets the function of a plethora of cell cycle regulators, including cyclin A, E and cyclin-dependent kinase inhibitor p21Cip1 and p27kip1 together with the metabolic regulators, acid-α-glucosidase and M2 pyruvate kinase. HPV E7 also interferes with the activity of a variety of cellular transcription factors, such as AP-1, p48, interferon regulatory factor-1 (IRF-1), forkhead transcription factor MPP2, TATA- box binding protein (TBP) and TATA-box binding protein- associated factor (TAF110), as well as with the Mi2 histone deacetylase activity. Also, E7 interacts with the S4 subunit of the 26S proteasome, a human homolog of the Drosophila tumor suppressor protein Tid56 (hTid-1), insulin-like growth factor binding protein (IGFBP-3) and histone H1 kinase (Table 2) (17, 18).
In a proteomic study using E7-transfected C33A cell lines, cytoskeletal proteins, such as actin and myosin V, were down-regulated by E7 (19). Tumor suppressor integrase interactor 1 protein (INI), ING1, and a novel protein, DJ579F20.2.1, (similar to transcriptional repressor CTCF) were suppressed by E7. E7 was also found to down-regulate chaperones, such as protein disulfide isomerase (PDI) A3. INI is a member of the ATP-dependent SWI/SNF chromatin remodeling complex, also known as tumor suppressor hSNF5/INI, which is mutated in sporadic and hereditary malignant rhabdoid tumors (20), causing G0-G1 cell cycle arrest (20). It was recently reported that the SWI/SNF complex plays an important role in p53-regulated cell cycle control (21), suggesting that the E7-induced down-regulation of hSNF5/INI may contribute to oncogenesis. ING1 is also suppressed by E7, and is a candidate tumor suppressor gene, which contributes to the process of malignant transformation and progression (22). ING1 is involved in DNA repair, apoptosis and chromatin remodeling, and is known to share several biological functions with p53, including cell cycle arrest, DNA repair and apoptosis, and is down-regulated in various cancers, such as breast and gastric cancer (22). However, the relationship between ING1 and the HPV oncoprotein remains to be reported. The mechanism by which E7 inhibits the expression of ING1 should also be elucidated. PDI is an enzyme that catalyzes the formation and isomerization of disulfide bonds, which has peptide binding and chaperone activity for cell adhesion, and is also involved in cell-cell interaction and gene expression. This report demonstrates that E7 can evade immune surveillance and resist apoptosis by suppressing or inducing various factors, such as immune- regulatory, cell signaling and cell cycle regulatory factors.
In HaCaT keratinocytes, E7 was found to down-regulate cytoplasmic actin and the leukocyte elastase inhibitor (LEI) (23). Actin plays an essential role in regulating cell structure during reorganization of cells via specific association with tight junctions. Neutrophil elastase is a protease involved in tissue destruction and inflammation, which characterizes numerous diseases, including hereditary emphysema, chronic obstructive pulmonary disease, cystic fibrosis, adult respiratory distress syndrome, ischemic-reperfusion injury and rheumatoid arthritis (24). Thus, elastase has been the object of extensive research in the development of potent inhibitors targeting its destructive and pro-inflammatory actions (24). This data suggests E7 may be involved in the modulation of elastase activity due to the down-regulation of LEI expression. Chaperone-related proteins, such as HSP60 and cytosolic chaperonin-containing T-complex polypeptide 1 (CCT), were up-regulated. HSP60 is known to be highly expressed in various cancers (25), is presumed may interact with a variety of cellular proteins and has a role in cervical carcinogenesis (25). CCT is a molecular chaperone that plays an important role in the folding of proteins in eukaryotic cytosol. Actin, tubulin and several other proteins are known to be folded by CCT. CCT expression is strongly up-regulated during cell growth, especially from the G1/S transition to the early S phase. CCT is expected to play important roles in the growth of cancer cells by assisting the folding of tubulin andother proteins (26). Ku70BP was up-regulated by E7 in 2-DE, with Ku70 and Ku80 essential for DNA double-strand break repair. It has been suggested that Ku70BP amplification and overexpression may be involved in the function of Ku70 in the DNA-PK complex implicated in the maintenance of genome stability and reduction of mutation frequency (27). E7-induced up-regulation of Ku70BP as been assumed to contribute to the functioning of Ku70, which plays roles in double-strand DNA break repair and maintenance of telomeres. Livin inhibitor-of-apoptosis, a novel human inhibitor of apoptosis protein (IAP) family members, termed 'livin', was induced by E7. The mRNA for livin was undetectable in most normal adult tissues, but was present in developmental tissues and several cancer cell lines. Livin was expressed in the nucleus and in a filamentous pattern throughout the cytoplasm. Disruption of livin may provide a strategy for the induction of apoptosis in certain cancer cells (28).
These results suggest that the infection of the E7 oncogene into epithelial cells can evade immune surveillance or resist against apoptosis by inducing or binding to various factors, such as chaperone, cell signaling and cell cycle regulatory factors.
Cervical cancer is a worldwide public health problem among women, especially in emerging nations. To improve the control of cervical cancer, new adjuvant diagnostic and therapeutic strategies are required. Advances in immunology, genomics and proteomics have accelerated our understanding of the genetic and cellular basis of many cancer types. Cervical cancer is a member of the virus-related neoplasms, with its initiation and promotion associated with persistent infection of oncogenic HPV.
The application of functional genomics and proteomics to query cervical cancer tissue specimens has yielded novel cancer biomarkers, but these require further validation. The integration of molecular and proteomic biotechnology with immunology has also yielded promising findings that may translate into clinically relevant biological assays. The studies of host proteins associated with HPV E6 and E7 oncoproteins continue to display potential future usage in the management of cervical cancer. Subsequent scientific investigations will probably yield new diagnostic and prognostic tools for cervical cancer, provide insights into its underlying biology and contribute to the development of novel management strategies.
Proteomics is now widely accepted as a useful tool in the development of molecular diagnosis and the identification of disease biomarkers in the post-genomic era. Proteomics also promises lower R&D costs, with the opportunities of new revenue streams through the identification of new drug targets in the treatment of various cancers. This review identifies the key technologies that will enable pharmaceutical companies to develop new niche products, improve drug attrition rates, increase the speed of clinical development and target new drug markets.

This work was supported by the Korea Science and Engineering Fund through the Cancer Metastasis Research Center (CMRC) at Yonsei University (R11-2000-082-02007-0 (2004)).

  • 1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–19. PMID: 10451482ArticlePubMed
  • 2. Lipari F, McGibbon GA, Wardrop E, Cordingley MG. Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry. 2001;40:1196–1204. PMID: 11170444ArticlePubMed
  • 3. Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 1991;67:547–556. PMID: 1657399ArticlePubMed
  • 4. Jones DL, Munger K. Interactions of the human papillomavirus E7 protein with cell cycle regulators. Semin Cancer Biol. 1996;7:327–337. PMID: 9284525ArticlePubMed
  • 5. Lipinski MM, Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene. 1999;18:7873–7882. PMID: 10630640ArticlePubMed
  • 6. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA. 1992;89:4549–4553. PMID: 1316611ArticlePubMedPMC
  • 7. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 1995;9:2335–2349. PMID: 7557386ArticlePubMed
  • 8. Filippova M, Parkhurst L, Duerksen-Hughes PJ. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. J Biol Chem. 2004;279:25729–25744. PMID: 15073179ArticlePubMed
  • 9. Yim EK, Meoyng J, Namakoong SE, Um SJ, Park JS. Genomic and proteomic expression patterns in HPV-16 E6 gene transfected stable human carcinoma cell lines. DNA Cell Biol. 2004;23:826–835. PMID: 15684709ArticlePubMed
  • 10. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129–1136. PMID: 2175676ArticlePubMed
  • 11. Degenhardt K, Sundararajan R, Lindsten T, Thompson C, White E. Bax and Bak independently promote cytochrome C release from mitochondria. J Biol Chem. 2002;277:14127–14134. PMID: 11836241ArticlePubMed
  • 12. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell. 2001;8:705–711. PMID: 11583631ArticlePubMed
  • 13. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. TRAF6 is a signal transducer for interleukin-1. Nature. 1996;383:443–446. PMID: 8837778ArticlePubMed
  • 14. Kaufmann WK, Schwartz JL, Hurt JC, Byrd LL, Galloway DA, Levedakou E, et al. Inactivation of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6. Cell Growth Differ. 1997;8:1105–1114. PMID: 9342189PubMed
  • 15. Park JS, Kim EJ, Lee JY, Sin HS, Namkoong SE, Um SJ. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by the human papillomavirus E6 proteins. Int J Cancer. 2001;91:822–827. PMID: 11275986ArticlePubMed
  • 16. Yim EK, Um SJ, Park JS. Interaction of HPV E6 oncoprotein with the novel protein, BARD1 (BRCA1-associated ring domain 1) and its biological role. 2005. In: 22nd Intl. Papillomavirus Conference;
  • 17. Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein; implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem. 2000;275:6764–6769. PMID: 10702232ArticlePubMed
  • 18. Barnard P, McMillan NA. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology. 1999;259:305–313. PMID: 10388655ArticlePubMed
  • 19. Lee KA, Shim JH, Kho CW, Park SG, Park BC, Kim JW, et al. Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics. Proteomics. 2004;4:839–848. PMID: 14997504ArticlePubMed
  • 20. Versteege I, Medjkane S, Rouillard D, Delattre O. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene. 2002;21:6403–6412. PMID: 12226744ArticlePubMed
  • 21. Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem. 2002;277:22330–22337. PMID: 11950834ArticlePubMed
  • 22. Tokunaga E, Maehara Y, Oki E, Kitamura K, Kakeji Y, Ohno S, et al. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett. 2000;152:15–22. PMID: 10754201ArticlePubMed
  • 23. Lee KA, Kang JW, Shim JH, Kho CW, Park SG, Lee HG, et al. Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics. Gynecol Oncol. 2005;99:142–152. PMID: 16038965ArticlePubMed
  • 24. Tremblay GM, Janelle MF, Bourbonnais Y. Anti-inflammatory activity of neutrophil elastase inhibitors. Curr Opin Investig Drugs. 2003;4:556–565. PubMed
  • 25. Kimura E, Enns RE, Thiebaut F, Howell SB. Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line. Cancer Chemother Pharmacol. 1993;32:279–285. PMID: 8100743ArticlePubMed
  • 26. Yokota S, Yanagi H, Yura T, Kubota H. Cytosolic chaperonin is up-regulated during cell growth Preferential expression and binding to tubulin at G(1)/S transition through early S phase. J Biol Chem. 1999;274:37070–37078. PMID: 10601265ArticlePubMed
  • 27. Song K, Jung D, Jung Y, Lee SG, Lee I. Interaction of human Ku70 with TRF2. FEBS Lett. 2000;481:81–85. PMID: 10984620ArticlePubMed
  • 28. Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem. 2001;276:3238–3246. PMID: 11024045ArticlePubMed
Fig. 1
HPV E6 and E7 binding to P53, with Rb interfering with the normal functions of the tumor suppressors.
crt-37-319-g001.jpg
Table 1
Cellular binding partners for HPV E6
crt-37-319-i001.jpg
Table 2
Cellular binding partners for HPV E7
crt-37-319-i002.jpg

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage
      Radoslaw Szmyd, Sienna Casolin, Lucy French, Anna G. Manjón, Melanie Walter, Léa Cavalli, Christopher B. Nelson, Scott G. Page, Andrew Dhawan, Eric Hau, Hilda A. Pickett, Harriet E. Gee, Anthony J. Cesare
      Nature Cell Biology.2025; 27(1): 59.     CrossRef
    • Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer
      Queenie Fernandes, Lubna Therachiyil, Shahd M Younis, Said Dermime, Ala-Eddin Al Moustafa
      Expert Review of Proteomics.2025;[Epub]     CrossRef
    • Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical Cancer Cells
      Warattaya Wattanathavorn, Masahide Seki, Yutaka Suzuki, Supranee Buranapraditkun, Nakarin Kitkumthorn, Thanayod Sasivimolrattana, Parvapan Bhattarakosol, Arkom Chaiwongkot
      International Journal of Molecular Sciences.2024; 25(5): 2535.     CrossRef
    • It Is All about Probiotics to Control Cervical Cancer
      Sumel Ashique, Abdul Faruk, Farhan Jalees Ahmad, Tasneem Khan, Neeraj Mishra
      Probiotics and Antimicrobial Proteins.2024; 16(3): 979.     CrossRef
    • Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line
      Andrés Cardona-Mendoza, Angela Fonseca-Benitez, Diana Marcela Buitrago, Ericsson Coy-Barrera, Sandra J. Perdomo
      Journal of Ethnopharmacology.2024; 319: 117225.     CrossRef
    • HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells
      Midhunaraj Kunnummal, Pooja Sherly Raveendran, Budhaditya Basu, Sheri Vidya Rani, Riya Ann Paul, Krithiga Kuppusamy, Mary Angelin, Joby Issac, Jackson James, Ani V. Das
      Cellular Oncology.2024; 47(3): 917.     CrossRef
    • Cis‐regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers
      Anurag Kumar Singh, Kaivalya Walavalkar, Daniele Tavernari, Giovanni Ciriello, Dimple Notani, Radhakrishnan Sabarinathan
      Molecular Oncology.2024; 18(5): 1189.     CrossRef
    • The microbiome and gynecologic cancer: cellular mechanisms and clinical applications
      Julia Chalif, Heather Wang, Daniel Spakowicz, Allison Quick, Elizabeth K Arthur, David O’Malley, Laura M Chambers
      International Journal of Gynecological Cancer.2024; 34(2): 317.     CrossRef
    • Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case‐cohort study
      Christiana Kartsonaki, Pang Yao, Julia Butt, Rima Jeske, Catherine de Martel, Martyn Plummer, Dianjianyi Sun, Sarah Clark, Robin G. Walters, Yiping Chen, Jun Lv, Canqing Yu, Michael Hill, Richard Peto, Liming Li, Tim Waterboer, Zhengming Chen, Iona Y. Mil
      International Journal of Cancer.2024; 154(8): 1423.     CrossRef
    • Serum oxidative biomarkers associated with genital HPV infection and cervical lesions in women
      Hui‐Yi Lin, Xiaodan Zhu, Harun Or Rashid Mazumder, Martin Ronis, Kim Brint Pedersen, Michael Hagensee
      Journal of Medical Virology.2024;[Epub]     CrossRef
    • Combined amplification-based single-molecule fluorescence in situ hybridization with immunofluorescence for simultaneous in situ detection of RNAs and proteins
      Yinghui Qiu, Kaipeng Wei, Hui Lin, Yanxiu Liu, Chen Lin, Rongqin Ke
      Biochemical and Biophysical Research Communications.2024; 696: 149508.     CrossRef
    • PARP1, DIDO3, and DHX9 Proteins Mutually Interact in Mouse Fibroblasts, with Effects on DNA Replication Dynamics, Senescence, and Oncogenic Transformation
      Agnes Fütterer, Sara Rodriguez-Acebes, Juan Méndez, Julio Gutiérrez, Carlos Martínez-A
      Cells.2024; 13(2): 159.     CrossRef
    • Technologies of gene editing and related clinical trials for the treatment of genetic and acquired diseases: a systematic review
      Wessam Sharaf-Eldin
      Egyptian Journal of Medical Human Genetics.2024;[Epub]     CrossRef
    • The role of viruses in cancer progression versus cancer treatment: A dual paradigm
      Somya Ranjan Dash, Anushka Kundu, Chanakya Nath Kundu
      Life Sciences.2024; 341: 122506.     CrossRef
    • Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases—Focus on Epigenetic Mechanisms
      Marta Włodarczyk, Michał Ciebiera, Grażyna Nowicka, Tomasz Łoziński, Mohamed Ali, Ayman Al-Hendy
      Nutrients.2024; 16(4): 559.     CrossRef
    • Unveiling HPV's hidden link: Cardiovascular diseases and the viral intrigue
      Preyangsee Dutta, Dwaipayan Saha, Mrudul Earle, Chandra Prakash Prasad, Mayank Singh, Mrinalini Darswal, Vipul Aggarwal, Nitish Naik, Rakesh Yadav, Abhishek Shankar, Abhijit Chakraborty
      Indian Heart Journal.2024; 76(1): 1.     CrossRef
    • Regulation and tumor‐suppressive function of the miR‐379/miR‐656 (C14MC) cluster in cervical cancer
      Sriharikrishnaa Srinath, Padacherri Vethil Jishnu, Vinay Koshy Varghese, Vaibhav Shukla, Divya Adiga, Sandeep Mallya, Sanjiban Chakrabarty, Krishna Sharan, Deeksha Pandey, Aniruddha Chatterjee, Shama Prasada Kabekkodu
      Molecular Oncology.2024; 18(6): 1608.     CrossRef
    • Comprehensive analysis of a novel subtype of immune microenvironment-derived HPV-infected colorectal cancer
      Jianlong Zhou, Yongfeng Liu, Yucheng Zhang, Fa Ling, Jiabin Zheng, Xueqing Yao, Zejian Lyu, Huolun Feng, Yong Li
      Microbes and Infection.2024; 26(4): 105315.     CrossRef
    • Evolution of Pathological Techniques for the Screening of Cervical Cancer: A Comprehensive Review
      Priya B Chatterjee, Snehlata R Hingway, Kishor M Hiwale
      Cureus.2024;[Epub]     CrossRef
    • Therapeutic Response to Treatment of a Papillomatous Ocular Surface Squamous Neoplasia With Intramuscular Human Papillomavirus Vaccine
      Mike Zein, Sofia De Arrigunaga, Mona M. Amer, Anat Galor, Anna J. Nichols, Tim Ioannides, Sander R. Dubovy, Carol L. Karp
      Cornea.2024;[Epub]     CrossRef
    • BRCA1 deficiency enhances the aggressiveness of breast cancer cells expressing HPV16 oncoproteins
      Jariya Sangthong, Chanitra Thuwajit, Laran T. Jensen, Waraporn Komyod, Jirundon Yuvaniyama, Mathurose Ponglikitmongkol
      Biology of the Cell.2024;[Epub]     CrossRef
    • Exploring the Relationship between Ovarian Cancer and Genital Microbiota: A Systematic Review and Meta-Analysis
      Vito Andrea Capozzi, Giosuè Giordano Incognito, Elisa Scarpelli, Marco Palumbo, Cinzia Lucia Randazzo, Alessandra Pino, Marco La Verde, Carlo Ronsini, Gaetano Riemma, Michela Gaiano, Paola Romeo, Vittorio Palmara, Roberto Berretta, Stefano Cianci
      Journal of Personalized Medicine.2024; 14(4): 351.     CrossRef
    • Virus-like Particles for Disease Diagnosis and Drug Delivery Applications
      Rishav Sharma, Rishabha Malviya
      Current Nanoscience.2024; 20(5): 613.     CrossRef
    • Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva
      Fiona Deutsch, Dayna Sais, Ni Keatinge, Meredith Hill, Ngoc Ha Tran, Michael Elliott, Nham Tran
      BMC Cancer.2024;[Epub]     CrossRef
    • Biochemical and toxicity evaluation of Retama sphaerocarpa extracts and in-silico investigation of phenolic compounds as potential inhibitors against HPV16 E6 oncoprotein
      Soumia Moujane, Ismail Bouadid, Aziz Bouymajane, Filali Zegzouti Younes, Mohamed Benlyas, Bouachrine Mohammed, Francesco Cacciola, Roberto Laganà Vinci, Alessia Tropea, Luigi Mondello, Ammar B. Altemimi, Mohamed Eddouks, Benaissa Moualij
      Fitoterapia.2024; 175: 105923.     CrossRef
    • Viruses in glioblastoma: an update on evidence and clinical trials
      Bavani Gunasegaran, Caroline L. Ashley, Felix Marsh-Wakefield, Gilles J. Guillemin, Benjamin Heng
      BJC Reports.2024;[Epub]     CrossRef
    • Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity
      Alan S. Futran, Tao Lu, Katherine Amberg-Johnson, Jiayi Xu, Xiaoxiao Yang, Saidi He, Sarah Boyce, Jeffrey A. Bell, Robert Pelletier, Takao Suzuki, Xianhai Huang, Heng Qian, Liping Fang, Li Xing, Zhaowu Xu, Stephen E. Kurtz, Jeffrey W. Tyner, Wayne Tang, T
      iScience.2024; 27(5): 109693.     CrossRef
    • Emerging biomarkers and molecular targets for precision medicine in cervical cancer
      Pankaj Garg, Madhu Krishna, Ayalur Raghu Subbalakshmi, Sravani Ramisetty, Atish Mohanty, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal
      Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2024; 1879(3): 189106.     CrossRef
    • Unfurling the functional association between long intergenic noncoding RNAs (lincRNAs) and HPV16-related cervical cancer pathogenesis through weighted gene co-expression network analysis of differentially expressed lincRNAs and coding genes
      Abarna Sinha, Sahana Ghosh, Abhisikta Ghosh, Arnab Ghosh, Sonia Mathai, Jaydip Bhaumik, Asima Mukhopadhyay, Arindam Maitra, Nidhan K Biswas, Sharmila Sengupta
      Carcinogenesis.2024; 45(7): 451.     CrossRef
    • Two Lineages of Papillomaviruses Identified from Caracals (Caracal caracal) in South Africa
      Simona Kraberger, Laurel E. K. Serieys, Gabriella R. M. Leighton, Matthew D. De Koch, John S. Munday, Jacqueline M. Bishop, Arvind Varsani
      Viruses.2024; 16(5): 701.     CrossRef
    • Molecular Typing of Human Leukocyte Antigen-Class I (HLA-A, HLA-B) & Human Leukocyte Antigen-Class II (HLA-DR) in Carcinoma Cervix and Its Association with Staging
      Sumanta Das, Mukul Singh, Anjali Sharma, R. Naveen Kumar, Adil Aziz Khan
      Indian Journal of Gynecologic Oncology.2024;[Epub]     CrossRef
    • Tumor-Derived Antigenic Peptides as Potential Cancer Vaccines
      Stanislav Sotirov, Ivan Dimitrov
      International Journal of Molecular Sciences.2024; 25(9): 4934.     CrossRef
    • CRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X
      Ashley Dobransky, Mary Root, Nicholas Hafner, Matty Marcum, H. John Sharifi
      Viruses.2024; 16(8): 1313.     CrossRef
    • Impact of human papillomavirus types on uterine cervical neoplasia
      Ayumi Taguchi, Daisuke Yoshimoto, Misako Kusakabe, Satoshi Baba, Akira Kawata, Yuichiro Miyamoto, Mayuyo Mori, Kenbun Sone, Yasushi Hirota, Yutaka Osuga
      Journal of Obstetrics and Gynaecology Research.2024; 50(8): 1283.     CrossRef
    • Quantification of HPV16 E7 Oncoproteins in Urine Specimens from Women with Cervical Intraepithelial Neoplasia
      Daiki Makioka, Mikio Inada, Masayuki Awano, Ema Saito, Takuya Shinoda, Satoko Abe, Teruki Yoshimura, Martin Müller, Toshiyuki Sasagawa, Etsuro Ito
      Microorganisms.2024; 12(6): 1205.     CrossRef
    • Assessing bias in the causal role of HPV in oral cancer: A systematic review and meta‐analysis
      Gagandeep Kaur, Tami Yap, Rishi Ramani, Michael McCullough, Ankur Singh
      Oral Diseases.2024; 30(8): 5379.     CrossRef
    • Current status and future directions for the development of human papillomavirus vaccines
      Rui Wang, Hongpeng Huang, Chulin Yu, Xuefeng Li, Yang Wang, Liangzhi Xie
      Frontiers in Immunology.2024;[Epub]     CrossRef
    • Exosome‐based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV‐mediated cervical cancer treatment
      Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh
      Clinical and Translational Discovery.2024;[Epub]     CrossRef
    • Human papillomavirus‐16 E6‐positive cervical cancer attenuated by potent 2‐(4‐biphenylyl)‐N‐(1‐ethyl‐4‐piperidinyl) acetamide second‐generation analogs with improved binding affinity
      Ashish Kumar
      Biotechnology and Applied Biochemistry.2024; 71(6): 1428.     CrossRef
    • Transforming growth factor-β micro-environment mediated immune cell functions in cervical cancer
      Jayapradha Gnanagurusamy, Sneha Krishnamoorthy, Sridhar Muthusami
      International Immunopharmacology.2024; 140: 112837.     CrossRef
    • Harnessing virulence factor-derived peptides for innovative oral cancer treatment
      Karthikeyan Kandaswamy, Ajay Guru
      Natural Product Research.2024; : 1.     CrossRef
    • Oncoviral Infections and Small Extracellular Vesicles
      Łukasz Ważny, Theresa L. Whiteside, Monika Pietrowska
      Viruses.2024; 16(8): 1291.     CrossRef
    • Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment
      Xolisiwe Sebutsoe, Nrateng Tsotetsi, Zodwa Jantjies, Portia Pheladi Raphela-Choma, Mpho Choene, lesetja R Motadi
      OncoTargets and Therapy.2024; Volume 17: 785.     CrossRef
    • Bovine papillomavirus gene expression and inflammatory pathway activation vary between equine sarcoid tumour subtypes
      Nicholas J. Parkinson, Abby Ward, Alexandra J. Malbon, Richard J.M. Reardon, Padraig G. Kelly
      Veterinary Immunology and Immunopathology.2024; 277: 110838.     CrossRef
    • Small non-coding RNAs as diagnostic, prognostic and predictive biomarkers of gynecological cancers: an update
      Marios A. Diamantopoulos, Panagiotis G. Adamopoulos, Andreas Scorilas
      Expert Review of Molecular Diagnostics.2024; 24(11): 979.     CrossRef
    • The role of transforming growth factor β in cervical carcinogenesis
      Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Eliza Pizarro Castilha, Mariane Ricciardi da Silva, Fernanda Costa Brandão Berti, Karen Brajão de Oliveira
      Cytokine & Growth Factor Reviews.2024; 80: 12.     CrossRef
    • A Self-Amplifying Human Papillomavirus 16 Vaccine Candidate Delivered by Tobacco Mosaic Virus-Like Particles
      Sweta Karan, Jessica Fernanda Affonso De Oliveira, Miguel A. Moreno-Gonzalez, Nicole F. Steinmetz
      ACS Applied Bio Materials.2024; 7(11): 7675.     CrossRef
    • A State‐of‐the‐Art Review on the Recent Advances in Exosomes in Oncogenic Virus
      Fatemeh Ebrahimi, Ali Modaresi Movahedi, Mohammad Sabbaghian, Vahdat Poortahmasebi
      Health Science Reports.2024;[Epub]     CrossRef
    • miRNAs Dysregulated in Human Papillomavirus-Associated Benign Prostatic Lesions and Prostate Cancer
      Sandra Viridiana Salgado-Hernández, Lucero Martínez-Retamoza, Rodolfo Ocadiz-Delgado, Salvador Pérez-Mora, Gladys Edith Cedeño-Arboleda, María del Consuelo Gómez-García, Patricio Gariglio, David Guillermo Pérez-Ishiwara
      Cancers.2024; 17(1): 26.     CrossRef
    • Association between mutant E6 and E7 Human Papilloma Virus Type 16 oncogenes with cyclin D1 expression in cervical cancer: Observational study in Bali
      I Nyoman Bayu Mahendra, I Nyoman Gede Budiana, I Gede Mega Putra, Anom Suardika, Anak Agung Gede Putra Wiradnyana, Alisza Novrita Sari
      F1000Research.2023; 12: 257.     CrossRef
    • Human papillomavirus infection, cervical cancer and the less explored role of trace elements
      Anne Boyina Sravani, Vivek Ghate, Shaila Lewis
      Biological Trace Element Research.2023; 201(3): 1026.     CrossRef
    • Viral subversion of the cell polarity regulator Scribble
      Airah Javorsky, Patrick O. Humbert, Marc Kvansakul
      Biochemical Society Transactions.2023;[Epub]     CrossRef
    • High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications
      Priyanka Dutta, Mukta Basu, Anup Roy, Ranajit Kumar Mandal, Chinmay Kumar Panda
      Journal of Molecular Histology.2023; 54(1): 89.     CrossRef
    • p15INK4B is an alternative marker of senescent tumor cells in colorectal cancer
      Soon Sang Park, Young-Kyoung Lee, So Hyun Park, Su Bin Lim, Yong Won Choi, Jun Sang Shin, Young Hwa Kim, Jang-Hee Kim, Tae Jun Park
      Heliyon.2023; 9(2): e13170.     CrossRef
    • Evaluation of the proteomic landscape of HPV E7‑induced alterations in human keratinocytes reveal therapeutically relevant pathways for cervical cancer
      Sivasangkary Gandhi, Muhammad Fazril Mohamad Razif, Shatrah Othman, Sajib Chakraborty, Nurshamimi Nor Rashid
      Molecular Medicine Reports.2023;[Epub]     CrossRef
    • Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
      Alexandra Lainé, Andrea M. Gonzalez-Lopez, Uzma Hasan, Ryotaro Ohkuma, Isabelle Ray-Coquard
      Cancers.2023; 15(7): 2042.     CrossRef
    • Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
      Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, Arun Asif, Chethikkattuveli Salih Abdul Rahim, Anupama Samantasinghar, Fida Hussain Memon, Kyung Hyun Choi
      Journal of Medical Virology.2023;[Epub]     CrossRef
    • Protein–DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis
      Roxanne Evande, Anshul Rana, Esther E. Biswas-Fiss, Subhasis B. Biswas
      International Journal of Molecular Sciences.2023; 24(10): 8493.     CrossRef
    • Histopathologic and molecular characterization of Erethizon dorsatum papillomavirus 1 and Erethizon dorsatum papillomavirus 2 infection in North American porcupines (Erethizon dorsatum)
      Zoe E. Mack, Leonardo C. Caserta, Randall W. Renshaw, Shotaro Nakagun, Rhea S. Gerdes, Diego G. Diel, Sara E. Childs-Sanford, Jeanine Peters-Kennedy
      Veterinary Pathology.2023; 60(6): 898.     CrossRef
    • Whole-Genome Doubling as a source of cancer: how, when, where, and why?
      Natalia Sanz-Gómez, María González-Álvarez, Javier De Las Rivas, Guillermo de Cárcer
      Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
    • Retrospective Phylodynamic and Phylogeographic Analysis of the Human Papillomavirus 16 E6 Gene in the Mediterranean Region
      Oussama Souiai, Ameni Sallemi
      Bioinformatics and Biology Insights.2023;[Epub]     CrossRef
    • MicroRNAs as Potential Biomarkers in Gynecological Cancers
      Joanna Miśkiewicz, Aleksandra Mielczarek-Palacz, Joanna Magdalena Gola
      Biomedicines.2023; 11(6): 1704.     CrossRef
    • Impact of Dietary Quality on Genital Oncogenic Human Papillomavirus Infection in Women
      Hui-Yi Lin, Qiufan Fu, Tung-sung Tseng, Xiaodan Zhu, Krzysztof Reiss, L Joseph Su, Michael E Hagensee
      The Journal of Infectious Diseases.2023; 228(10): 1385.     CrossRef
    • Prevalence of P16 Immunohistochemistry Positive Staining and Its Correlation to Clinical and Radiological Staging of Squamous Cell Carcinoma of the Cervix
      Hossam H. El Sokkary, Eman Sheta
      The Journal of Obstetrics and Gynecology of India.2023; 73(S1): 142.     CrossRef
    • HPV-associated cancers: insights into the mechanistic scenario and latest updates
      Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Rama Jayaraj, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Sabina Evan Prince, Balachandar Vellingiri, Abhijit Dey, Kaviyarasi Renu
      Medical Oncology.2023;[Epub]     CrossRef
    • Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy
      Kaijian Ling, Yin Dou, Neng Yang, Li Deng, Yanzhou Wang, Yudi Li, Leiyan Yang, Cheng Chen, Lupin Jiang, Qingchun Deng, Chenwen Li, Zhiqing Liang, Jianxiang Zhang
      Journal of Controlled Release.2023; 360: 496.     CrossRef
    • Viral manipulation of cell polarity signalling
      Airah Javorsky, Patrick O. Humbert, Marc Kvansakul
      Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2023; 1870(7): 119536.     CrossRef
    • The Undefinable Links: Unraveling the Mysterious Relationships Between Viruses and the Human
      Yuening Li
      Highlights in Science, Engineering and Technology.2023; 54: 397.     CrossRef
    • Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications
      Daniel Sausen, Oren Shechter, Elisa Gallo, Harel Dahari, Ronen Borenstein
      Cancers.2023; 15(14): 3692.     CrossRef
    • The potential role of the microbiota in prostate cancer pathogenesis and treatment
      Nicolò Pernigoni, Christina Guo, Lewis Gallagher, Wei Yuan, Manuel Colucci, Martina Troiani, Lei Liu, Luisa Maraccani, Ilaria Guccini, Denis Migliorini, Johann de Bono, Andrea Alimonti
      Nature Reviews Urology.2023; 20(12): 706.     CrossRef
    • Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carcinogenesis
      Allison J. Cox, William E. Crowe, Qi Yang, Bin Zhang, Zoltán N. Oltvai, Xiaoyan Liao
      Modern Pathology.2023; 36(11): 100295.     CrossRef
    • An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis
      Usman Ayub Awan, Aamer Ali Khattak, Noman Ahmed, Xingyi Guo, Sohail Akhtar, Shehrish Kamran, Zhao Yongjing, Jianbo Liu, Suliman Khan
      Frontiers in Oncology.2023;[Epub]     CrossRef
    • Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications
      Priyanka Dutta, Debolina Pal, Anup Roy, Ranajit Kumar Mandal, Chinmay Kumar Panda
      Gene.2023; 888: 147746.     CrossRef
    • Detection of High-Grade Cervical Intraepithelial Neoplasia by Electrical Impedance Spectroscopy in Women Diagnosed with Low-Grade Cervical Intraepithelial Neoplasia in Cytology
      Georgios Panagakis, Ioannis K. Papapanagiotou, Charalampos Theofanakis, Paraskevi Tsetsa, Adamantia Kontogeorgi, Nikolaos Thomakos, Alexandros Rodolakis, Dimitrios Haidopoulos
      Life.2023; 13(11): 2139.     CrossRef
    • MULTİPL SKLEROZ HASTALARINDA SERVİKAL DİSPLAZİ RİSKİ
      Özlem Kayacık Günday, Gökçe Zeytin Demiral, Şerafettin Baysal, Tacettin Sevim, Selin Yoldaş, Berkay Çelebi, Ensar Çam
      Kocatepe Tıp Dergisi.2023; 24(4): 493.     CrossRef
    • p16/Ki67 dual stain triage versus cytology in primary human papillomavirus‐based cervical cancer screening with limited genotyping
      Martyna Trzeszcz, Maciej Mazurec, Robert Jach, Karolina Mazurec, Izabela Kotkowska‐Szeps, Magdalena Kania, Mariola Wantuchowicz, Jolanta Wasowska, Monika Duczek‐Polakiewicz, Patrycja Rozmus, Joanna Streb, Agnieszka Halon
      Journal of Medical Virology.2023;[Epub]     CrossRef
    • From Diagnosis to Treatment: Exploring the Latest Management Trends in Cervical Intraepithelial Neoplasia
      Saloni Gupta, Nikhilesh Nagtode, Vaibhav Chandra, Kavita Gomase
      Cureus.2023;[Epub]     CrossRef
    • Regulatory Effect of Ficus carica Latex on Cell Cycle Progression in Human Papillomavirus-Positive Cervical Cancer Cell Lines: Insights from Gene Expression Analysis
      Muharrem Cakir, Ugur Bilge, Arshia Ghanbari, G. Ashrafi
      Pharmaceuticals.2023; 16(12): 1723.     CrossRef
    • Leveraging innovative therapies with an evolving understanding of the molecular pathogenesis of penile squamous cell carcinoma
      Ali Hajiran, Taylor Bracco, Logan Zemp, Philippe E. Spiess
      Urologic Oncology: Seminars and Original Investigations.2022; 40(5): 173.     CrossRef
    • Antioxidant and Cytotoxic Activities of Exopolysaccharides from Alcaligenes faecalis Species Isolated from the Marine Environment of Mauritius
      Aadil Ahmad Aullybux, Daneshwar Puchooa, Theeshan Bahorun, Rajesh Jeewon, Xuesong Wen, Poona Matin
      Journal of Polymers and the Environment.2022; 30(4): 1462.     CrossRef
    • Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma
      Abeer M. Salama, Amir Momeni-Boroujeni, Chad Vanderbilt, Marc Ladanyi, Robert Soslow
      Modern Pathology.2022; 35(2): 274.     CrossRef
    • Haemophilus pittmaniae and Leptotrichia spp. Constitute a Multi-Marker Signature in a Cohort of Human Papillomavirus-Positive Head and Neck Cancer Patients
      Jean-Luc C. Mougeot, Micaela F. Beckman, Holden C. Langdon, Rajesh V. Lalla, Michael T. Brennan, Farah K. Bahrani Mougeot
      Frontiers in Microbiology.2022;[Epub]     CrossRef
    • Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials
      Jianming Tang, Mingzhu Li, Chao Zhao, Danhua Shen, Lei Liu, Xiujun Zhang, Lihui Wei
      Viruses.2022; 14(2): 239.     CrossRef
    • Modelling Chlamydia and HPV co-infection in patient-derived ectocervix organoids reveals distinct cellular reprogramming
      Stefanie Koster, Rajendra Kumar Gurumurthy, Naveen Kumar, Pon Ganish Prakash, Jayabhuvaneshwari Dhanraj, Sofia Bayer, Hilmar Berger, Shilpa Mary Kurian, Marina Drabkina, Hans-Joachim Mollenkopf, Christian Goosmann, Volker Brinkmann, Zachary Nagel, Mandy M
      Nature Communications.2022;[Epub]     CrossRef
    • Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
      Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth, Waleed M Hussein
      International Journal of Nanomedicine.2022; Volume 17: 869.     CrossRef
    • Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
      Paul Shafer, Lauren M. Kelly, Valentina Hoyos
      Frontiers in Immunology.2022;[Epub]     CrossRef
    • Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer
      Sadhana M Gupta, Himangi Warke, Hemangi Chaudhari, Padmaja Mavani, Rajshree D. Katke, Shilpa C. Kerkar, Jayanti Mania‐Pramanik
      Journal of Medical Virology.2022; 94(7): 3368.     CrossRef
    • Targeting metabolism: A potential strategy for hematological cancer therapy
      Xue Tang, Fen Chen, Li-Chun Xie, Si-Xi Liu, Hui-Rong Mai
      World Journal of Clinical Cases.2022; 10(10): 2990.     CrossRef
    • Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia
      Tafadzwa Chihanga, Sara Vicente-Muñoz, Sonya Ruiz-Torres, Bidisha Pal, Mathieu Sertorio, Paul R. Andreassen, Ruby Khoury, Parinda Mehta, Stella M. Davies, Andrew N. Lane, Lindsey E. Romick-Rosendale, Susanne I. Wells
      Cancers.2022; 14(8): 2040.     CrossRef
    • Current and future direction in treatment of HPV-related cervical disease
      Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
      Journal of Molecular Medicine.2022; 100(6): 829.     CrossRef
    • Parent Attitudes regarding Orthodontists’ Role as Potential Administrators of Human Papilloma Virus (HPV) Vaccines
      Gloria Lee, Jessica Begley, Kavita Ahluwalia, Jaffer A Shariff, Sunil Wadhwa, Christine O’Hea, Gaetano Isola
      International Journal of Dentistry.2022; 2022: 1.     CrossRef
    • Graphene Quantum Dots – Hydrothermal Green Synthesis, Material Characterization and Prospects for Cervical Cancer Diagnosis Applications: A Review
      Raghavv Raghavender Suresh, Arockia Jayalatha Kulandaisamy, Noel Nesakumar, Saisubramanian Nagarajan, Jung Heon Lee, John Bosco Balaguru Rayappan
      ChemistrySelect.2022;[Epub]     CrossRef
    • Interplay between cellular metabolism and DNA viruses
      Milad Zandi, Somayeh Shokri, Shahab Mahmoudvand, Ahmad Hosseinzadeh Adli, Ramin Mohammadi, Azita Haddadi
      Journal of Medical Virology.2022; 94(11): 5163.     CrossRef
    • Breast Cancer Risk and Human Papillomavirus Infection: A Bradford Hill Criteria Based Evaluation
      Muhammad Usman, Yasir Hameed, Mukhtiar Ahmad, Jalil Ur Rehman, Hamad Ahmed, Muhammad Safdar Hussain, Rizwan Asif, Muhammad Ghulam Murtaza, Muhammad Tayyab Jawad, Muhammad Junaid Iqbal
      Infectious Disorders - Drug Targets.2022;[Epub]     CrossRef
    • Sensor detection in gynaecological medicine
      Michael Thompson, Soha Ahmadi, Katharina Davoudian, Brian De La Franier, Navina Lotay, Marcus Q. Bernardini
      Sensors & Diagnostics.2022; 1(5): 877.     CrossRef
    • Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination
      Flávia M. Corrêa, Arn Migowski, Liz M. de Almeida, Marcelo A. Soares
      Frontiers in Medicine.2022;[Epub]     CrossRef
    • HPV-mediated Cervical Cancer: A Systematic Review on Immunological Basis, Molecular Biology, and Immune Evasion Mechanisms
      Ramar Vanajothi, Natarajan Srikanth, Rajendran Vijayakumar, Manikandan Palanisamy, Sundaresan Bhavaniramya, Kumpati Premkumar
      Current Drug Targets.2022; 23(8): 782.     CrossRef
    • Potential role of human papillomavirus proteins associated with the development of cancer
      Dhanvee Balaji, Iyshwarya Bhaskar Kalarani, Vajagathali Mohammed, Ramakrishnan Veerabathiran
      VirusDisease.2022; 33(3): 322.     CrossRef
    • Proton-induced DNA damage promotes integration of foreign plasmid DNA into human genome
      Meghri Katerji, Antonella Bertucci, Valery Filippov, Marcelo Vazquez, Xin Chen, Penelope J. Duerksen-Hughes
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Anti-cancer properties of Caulerpa racemosa by altering expression of Bcl-2, BAX, cleaved caspase 3 and apoptosis in HeLa cancer cell culture
      Happy Kurnia Permatasari, Defny Silvia Wewengkang, Nur Iedha Tertiana, Farida Zharfani Muslim, Muhammad Yusuf, Shintya Octaviana Baliulina, Vanessa Pradna Adyana Daud, Aurielle Annalicia Setiawan, Fahrul Nurkolis
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Does Lactobacillus Exert a Protective Effect on the Development of Cervical and Endometrial Cancer in Women?
      Karolina Frąszczak, Bartłomiej Barczyński, Adrianna Kondracka
      Cancers.2022; 14(19): 4909.     CrossRef
    • Cervical cancer screening: Past, present and outlook
      Radomir Živadinović, Aleksandra Petrić, Aleksandar Živadinović, Sonja Pop-Trajković, Lazar Živadinović, Dušan Simić
      Glasnik javnog zdravlja.2022; 96(3): 333.     CrossRef
    • HPV-18 E7 Interacts with Elk-1 Leading to Elevation of the Transcriptional Activity of Elk-1 in Cervical Cancer
      Sung-Ho Go, Seung Bae Rho, Dong-Wha Yang, Boh-Ram Kim, Chang Hoon Lee, Seung-Hoon Lee
      Biomolecules & Therapeutics.2022; 30(6): 593.     CrossRef
    • A Reverse Structure-based Design of HPV E7 Inhibitor
      Wan Chein Tan, Shatrah Othman, See Khai Lim, Nurshamimi Nor Rashid, Choon Han Heh
      Current Computer-Aided Drug Design.2022; 18(4): 318.     CrossRef
    • Investigation of Curcumin-Loaded OA400 Nanoparticle’s Effect on the Expression of E6 and E7 Human Papilloma-Virus Oncogenes and P53 and Rb Factors in HeLa Cell Line
      Rezvaneh Vahedian Sadeghi, Masoud Parsania, Majid Sadeghizadeh, Setareh Haghighat
      Iranian Journal of Pharmaceutical Research.2022;[Epub]     CrossRef
    • Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems
      Ingrid Andrêssa de Moura, Anna Jéssica Duarte Silva, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Mylenna Máyra Gois de Sousa, Antonio Carlos de Freitas
      Pathogens.2022; 11(12): 1444.     CrossRef
    • Effects of Human Papilloma Virus E6/E7 Oncoproteins on Genomic Structure in Head and Neck Squamous Cell Carcinoma
      Matthew Uzelac, Armon Barakchi, Varsha Beldona, Daniel John, Jaideep Chakladar, Wei Tse Li, Weg M. Ongkeko
      Cancers.2022; 14(24): 6190.     CrossRef
    • Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer
      Robert Polten, Ivana Kutle, Jens Hachenberg, Rüdiger Klapdor, Michael Morgan, Axel Schambach
      Cancers.2022; 15(1): 263.     CrossRef
    • The Presence of Human Papillomavirus and Epstein-Barr Virus Infection in Gastric Cancer: A Systematic Study
      Abolfazl Jafari-Sales, Afsoon Shariat, Hossein Bannazadeh Baghi, Behzad Baradaran, Behboud Jafari
      Oncologie.2022; 24(3): 413.     CrossRef
    • Immunology of HPV-mediated cervical cancer: current understanding
      Babban Jee, Renu Yadav, Sangeeta Pankaj, Shivendra Kumar Shahi
      International Reviews of Immunology.2021; 40(5): 359.     CrossRef
    • The role of human papillomavirus in the pathogenesis of sinonasal inverted papilloma: a narrative review
      Rohit Gupta, Peter L. Rady, Andrew G. Sikora, Stephen K. Tyring
      Reviews in Medical Virology.2021;[Epub]     CrossRef
    • The role of HPV gene expression and selected cellular MiRNAs in lung cancer development
      Bashdar Mahmud Hussen, Gelavizh Ahmadi, Havva Marzban, Maryam Ebadi Fard Azar, Saba Sorayyayi, Romina Karampour, Javid Sadri Nahand, Hazha Jamal Hidayat, Mohsen Moghoofei
      Microbial Pathogenesis.2021; 150: 104692.     CrossRef
    • Adjunctive testing by cytology, p16/Ki‐67 dual‐stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen‐positive women
      Leticia Torres‐Ibarra, Attila T. Lorincz, Cosette M. Wheeler, Jack Cuzick, Rubí Hernández‐López, Donna Spiegelman, Leith León‐Maldonado, Berenice Rivera‐Paredez, Pablo Méndez‐Hernández, Eduardo Lazcano‐Ponce, Jorge Salmerón
      International Journal of Cancer.2021; 148(9): 2264.     CrossRef
    • EGFR Protein Expression Relates with Tumor Histology, Methylation Status of EGFR and HPV16 E6 Viral Load in Oropharyngeal Carcinoma
      Yo Suzuki, Yuki Fukumura, Miki Asahina, Mitsuhisa Fujimaki, Shinichi Ohba, Fumihiko Matsumoto, Isao Kurahayashi, Takashi Yao, Katsuhisa Ikeda
      Head and Neck Pathology.2021; 15(3): 743.     CrossRef
    • An internal class III PDZ binding motif in HPV16 E6* protein is required for Dlg degradation activity
      Wareerat Umnajvijit, Jariya Sangthong, Fabien Loison, Kulthida Vaeteewoottacharn, Mathurose Ponglikitmongkol
      Biochimica et Biophysica Acta (BBA) - General Subjects.2021; 1865(5): 129850.     CrossRef
    • Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression
      Lacey R. Lopez, Rachel M. Bleich, Janelle C. Arthur
      Annual Review of Medicine.2021; 72(1): 243.     CrossRef
    • Ovulatory Follicular Fluid Facilitates the Full Transformation Process for the Development of High-Grade Serous Carcinoma
      Che-Fang Hsu, Pao-Chu Chen, Vaishnavi Seenan, Dah-Ching Ding, Tang-Yuan Chu
      Cancers.2021; 13(3): 468.     CrossRef
    • Is There a Carcinogenic Risk Attached to Vitamin B12 Deficient Diets and What Should We Do About It? Reviewing the Facts
      Alexandra K. Loedin, Dave Speijer
      Molecular Nutrition & Food Research.2021;[Epub]     CrossRef
    • Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
      Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew J. Easton, Gholamreza Ahmadian
      Journal of Nanobiotechnology.2021;[Epub]     CrossRef
    • Focus on HPV Infection and the Molecular Mechanisms of Oral Carcinogenesis
      Luigi Santacroce, Michele Di Cosola, Lucrezia Bottalico, Skender Topi, Ioannis Alexandros Charitos, Andrea Ballini, Francesco Inchingolo, Angela Pia Cazzolla, Gianna Dipalma
      Viruses.2021; 13(4): 559.     CrossRef
    • An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potent
      Giuseppe Angelico, Angela Santoro, Frediano Inzani, Patrizia Straccia, Saveria Spadola, Damiano Arciuolo, Michele Valente, Nicoletta D’Alessandris, Roberta Benvenuto, Antonio Travaglino, Antonio Raffone, Gian Franco Zannoni
      Diagnostics.2021; 11(4): 713.     CrossRef
    • Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications
      Rosalba De Nola, Vera Loizzi, Ettore Cicinelli, Gennaro Cormio
      Critical Reviews in Oncology/Hematology.2021; 162: 103343.     CrossRef
    • Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials
      Lejla Mahmutović, Esma Bilajac, Altijana Hromić-Jahjefendić
      Microorganisms.2021; 9(5): 1001.     CrossRef
    • Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women
      Khaoula HADAMI, Charles SABY, Nadia DAKKA, Guillaume COLLIN, Mohammed ATTALEB, Meriem KHYATTI, Abdelkarim FILALI-MALTOUF, Hamid MORJANI, Mohammed EL MZIBRI
      Gene.2021; 791: 145709.     CrossRef
    • The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
      Sylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye, Venugopal Balakrishnan
      Human Vaccines & Immunotherapeutics.2021; 17(9): 2981.     CrossRef
    • UVB Inhibits Proliferation, Cell Cycle and Induces Apoptosis via p53, E2F1 and Microtubules System in Cervical Cancer Cell Lines
      Angelica Judith Granados-López, Eduardo Manzanares-Acuña, Yamilé López-Hernández, Julio Enrique Castañeda-Delgado, Ixamail Fraire-Soto, Claudia Araceli Reyes-Estrada, Rosalinda Gutiérrez-Hernández, Jesús Adrián López
      International Journal of Molecular Sciences.2021; 22(10): 5197.     CrossRef
    • Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells
      Jinshun Zhu, Saidu Kamara, Qi Wang, Yanru Guo, Qingfeng Li, Linlin Wang, Jingjing Chen, Qianqian Du, Wangqi Du, Shao Chen, Shanli Zhu, Jun Chen, Maoping Chu, Lifang Zhang
      Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
    • Recent Progress in Electrochemical Detection of Human Papillomavirus (HPV) via Graphene‐Based Nanosensors
      Seyyed Mojtaba Mousavi, Gity Behbudi, Seyyed Alireza Hashemi, Aziz Babapoor, Wei-Hung Chiang, Seeram Ramakrishna, Mohammed Muzibur Rahman, Chin Wei Lai, Ahmad Gholami, Navid Omidifar, Khadije Yousefi, Bruno C. Janegitz
      Journal of Sensors.2021;[Epub]     CrossRef
    • Antioxidants Associated With Oncogenic Human Papillomavirus Infection in Women
      Hui-Yi Lin, Qiufan Fu, Yu-Hsiang Kao, Tung-sung Tseng, Krzysztof Reiss, Jennifer E Cameron, Martin J Ronis, Joseph Su, Navya Nair, Hsiao-Man Chang, Michael E Hagensee
      The Journal of Infectious Diseases.2021; 224(9): 1520.     CrossRef
    • The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities
      Laura M. Chambers, Parker Bussies, Roberto Vargas, Emily Esakov, Surabhi Tewari, Ofer Reizes, Chad Michener
      Current Oncology Reports.2021;[Epub]     CrossRef
    • Interpretations on the Interaction between Protein Tyrosine Phosphatase and E7 Oncoproteins of High and Low-Risk HPV: A Computational Perception
      Murali Aarthy, Sanjeev Kumar Singh
      ACS Omega.2021; 6(25): 16472.     CrossRef
    • Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry
      Soo Young Jeong, Joon-Yong Chung, Sun-Ju Byeon, Chul Jung Kim, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Ye Lin Chae, So Young Oh, Chel Hun Choi
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Viral load and interaction of HPV oncoprotein E6 and E7 with host cellular markers in the progression of cervical cancer
      Bilal Ahmad Mir, P. F. Rahaman, Arif Ahmad
      AIMS Molecular Science.2021; 8(3): 184.     CrossRef
    • Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma
      Jin Seol An, Jung Hwa Moon, Chayeon Kim, Joo Kyung No, Young Gyu Eun, Young Chang Lim
      Experimental Cell Research.2021; 407(2): 112815.     CrossRef
    • Reduced MAGI3 level by HPV18E6 contributes to Wnt/β‐catenin signaling activation and cervical cancer progression
      Zhuoli Yang, Hua Liu, Ran Song, Wenxiu Lu, Haibo Wang, Siyu Gu, Xuedi Cao, Yibin Chen, Jihuan Liang, Qiong Qin, Xiaomei Yang, Duiping Feng, Junqi He
      FEBS Open Bio.2021; 11(11): 3051.     CrossRef
    • An Integrated View of Virus-Triggered Cellular Plasticity Using Boolean Networks
      Jenny Paola Alfaro-García, María Camila Granados-Alzate, Miguel Vicente-Manzanares, Juan Carlos Gallego-Gómez
      Cells.2021; 10(11): 2863.     CrossRef
    • Role of interleukin-17 in human papillomavirus infection and associated malignancies
      Utkarsha Sahu, Prashant Khare
      Microbial Pathogenesis.2021; 161: 105294.     CrossRef
    • FNDC3B and BPGM Are Involved in Human Papillomavirus-Mediated Carcinogenesis of Cervical Cancer
      Luhan Zhang, Hong Yu, Tian Deng, Li Ling, Juan Wen, Mingfen Lv, Rongying Ou, Qiaozhi Wang, Yunsheng Xu
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Investigating host-virus interaction mechanism and phylogenetic analysis of viral proteins involved in the pathogenesis
      Ahmad Abu Turab Naqvi, Farah Anjum, Alaa Shafie, Sufian Badar, Abdelbaset Mohamed Elasbali, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan, Timir Tripathi
      PLOS ONE.2021; 16(12): e0261497.     CrossRef
    • Potential anticancer effect of aspirin and 2'‑hydroxy‑2,3,5'‑trimethoxychalcone‑linked polymeric micelles against cervical cancer through apoptosis
      Kang Lee, Suji Baek, Myeong Yoon, Ji Park, Bok Hong, Sang Lee, Seung Oh, Seung Kwon, Ruda Lee, Dae Lee, Kang-Seo Park, Byung Moon
      Oncology Letters.2021;[Epub]     CrossRef
    • HPVE6-USP46 Mediated Cdt2 Stabilization Reduces Set8 Mediated H4K20-Methylation to Induce Gene Expression Changes
      Shashi Kiran, Briana Wilson, Shekhar Saha, Julia Ann Graff, Anindya Dutta
      Cancers.2021; 14(1): 30.     CrossRef
    • Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review
      Jishnu Nair, Abhishek Nair, Soundaram Veerappan, Dwaipayan Sen
      Cancer Gene Therapy.2020; 27(3-4): 116.     CrossRef
    • Cancer signaling by plasmonic quantum probes
      Ayushi Agarwal, Krishnan Venkatakrishnan, Bo Tan
      Applied Materials Today.2020; 18: 100465.     CrossRef
    • Multistate Markov Model to Predict the Prognosis of High-Risk Human Papillomavirus-Related Cervical Lesions
      Ayumi Taguchi, Konan Hara, Jun Tomio, Kei Kawana, Tomoki Tanaka, Satoshi Baba, Akira Kawata, Satoko Eguchi, Tetsushi Tsuruga, Mayuyo Mori, Katsuyuki Adachi, Takeshi Nagamatsu, Katsutoshi Oda, Toshiharu Yasugi, Yutaka Osuga, Tomoyuki Fujii
      Cancers.2020; 12(2): 270.     CrossRef
    • Early-stage cervical cancer diagnosis based on an ultra-sensitive electrochemical DNA nanobiosensor for HPV-18 detection in real samples
      Pegah Mahmoodi, Majid Rezayi, Elisa Rasouli, Amir Avan, Mehrdad Gholami, Majid Ghayour Mobarhan, Ehsan Karimi, Yatima Alias
      Journal of Nanobiotechnology.2020;[Epub]     CrossRef
    • Cervical Cancer Screening: Past, Present, and Future
      Sarah L. Bedell, Lena S. Goldstein, Amelia R. Goldstein, Andrew T. Goldstein
      Sexual Medicine Reviews.2020; 8(1): 28.     CrossRef
    • Potential oncogenic roles of mutant-p53-derived exosomes in the tumor–host interaction of head and neck cancers
      Etti Ester Azulay, Tomer Cooks, Moshe Elkabets
      Cancer Immunology, Immunotherapy.2020; 69(2): 285.     CrossRef
    • Extracellular Vesicles from Human Papilloma Virus-Infected Cervical Cancer Cells Enhance HIV-1 Replication in Differentiated U1 Cell Line
      Sabina Ranjit, Sunitha Kodidela, Namita Sinha, Subhash Chauhan, Santosh Kumar
      Viruses.2020; 12(2): 239.     CrossRef
    • Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies
      Renjian Hu, Zhen Dong, Kui Zhang, Guangzhao Pan, Chongyang Li, Hongjuan Cui
      Viruses.2020; 12(3): 333.     CrossRef
    • Cell Cycle Profiling Reveals Protein Oscillation, Phosphorylation, and Localization Dynamics
      Patrick Herr, Johan Boström, Eric Rullman, Sean G. Rudd, Mattias Vesterlund, Janne Lehtiö, Thomas Helleday, Gianluca Maddalo, Mikael Altun
      Molecular & Cellular Proteomics.2020; 19(4): 608.     CrossRef
    • HPV Infection Significantly Accelerates Glycogen Metabolism in Cervical Cells with Large Nuclei: Raman Microscopic Study with Subcellular Resolution
      Katarzyna Sitarz, Krzysztof Czamara, Joanna Bialecka, Malgorzata Klimek, Barbara Zawilinska, Slawa Szostek, Agnieszka Kaczor
      International Journal of Molecular Sciences.2020; 21(8): 2667.     CrossRef
    • Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
      Shaian Tavakolian, Hossein Goudarzi, Ebrahim Faghihloo
      Infectious Agents and Cancer.2020;[Epub]     CrossRef
    • Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
      Mohsen Keshavarz, Mir Saeed Ebrahimzadeh, Seyed Mohammad Miri, Hassan Dianat-Moghadam, Seyedeh Sara Ghorbanhosseini, Seyed Reza Mohebbi, Hossein Keyvani, Amir Ghaemi
      Virology Journal.2020;[Epub]     CrossRef
    • Virus-Specific T Cells for the Treatment of Malignancies—Then, Now, and the Future
      Sandhya Sharma, Wingchi K Leung, Helen E Heslop
      Current Stem Cell Reports.2020; 6(2): 17.     CrossRef
    • The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers
      Claire D. James, Iain M. Morgan, Molly L. Bristol
      Pathogens.2020; 9(5): 403.     CrossRef
    • Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model
      Donia Alson, Scott C. Schuyler, Bo-Xin Yan, Karthika Samimuthu, Jiantai Timothy Qiu
      Frontiers in Immunology.2020;[Epub]     CrossRef
    • HPV‐related methylation‐based reclassification and risk stratification of cervical cancer
      Si Yang, Ying Wu, Shuqian Wang, Peng Xu, Yujiao Deng, Meng Wang, Kang Liu, Tian Tian, Yuyao Zhu, Na Li, Linghui Zhou, Zhijun Dai, Huafeng Kang
      Molecular Oncology.2020; 14(9): 2124.     CrossRef
    • Anti-tumor activities of probiotics in cervical cancer
      Moghaddaseh Jahanshahi, Parisa Maleki Dana, Bita Badehnoosh, Zatollah Asemi, Jamal Hallajzadeh, Mohammad Ali Mansournia, Bahman Yousefi, Bahram Moazzami, Shahla Chaichian
      Journal of Ovarian Research.2020;[Epub]     CrossRef
    • Dysregulation of Stemness Pathways in HPV Mediated Cervical Malignant Transformation Identifies Potential Oncotherapy Targets
      Megha Budhwani, Samuel W. Lukowski, Sandro V. Porceddu, Ian H. Frazer, Janin Chandra
      Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
    • Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner
      Da-Hyun Kim, Hyun-Woo Lee, Hyun-Woo Park, Han-Woong Lee, Kyung-Hee Chun
      BMB Reports.2020; 53(8): 419.     CrossRef
    • The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue
      Marzieh Rezaei, Shayan Mostafaei, Amir Aghaei, Nayyerehalsadat Hosseini, Hassan Darabi, Majid Nouri, Ashkan Etemadi, Andrew O’. Neill, Javid Sadri Nahand, Hamed Mirzaei, Seamas C. Donnelly, Mohammad Doroudian, Mohsen Moghoofei
      BMC Cancer.2020;[Epub]     CrossRef
    • The role of viruses in adenocarcinoma development
      Mohsen Nakhaie, Javad Charostad, Gholam Abbas Kaydani, Ebrahim Faghihloo
      Infection, Genetics and Evolution.2020; 86: 104603.     CrossRef
    • Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages
      Ayumi Taguchi, Kazunori Nagasaka, Charles Plessy, Hiroe Nakamura, Yoshiko Kawata, Sachi Kato, Kosuke Hashimoto, Takeshi Nagamatsu, Katsutoshi Oda, Iwao Kukimoto, Kei Kawana, Piero Carninci, Yutaka Osuga, Tomoyuki Fujii
      Scientific Reports.2020;[Epub]     CrossRef
    • Potential therapeutic and pharmacological effects of Wogonin: an updated review
      Do Luong Huynh, Tran Hoang Ngau, Nguyen Hoai Nguyen, Gia-Buu Tran, Cuong Thach Nguyen
      Molecular Biology Reports.2020; 47(12): 9779.     CrossRef
    • The Molecular and Pathophysiological Functions of Members of the LNX/PDZRN E3 Ubiquitin Ligase Family
      Jeongkwan Hong, Minho Won, Hyunju Ro
      Molecules.2020; 25(24): 5938.     CrossRef
    • Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology
      Joan Campbell-Tofte, Aristidis Vrahatis, Knud Josefsen, Jesper Mehlsen, Kaj Winther
      Cellular and Molecular Life Sciences.2019; 76(1): 67.     CrossRef
    • DNA methyltransferases in virus‐associated cancers
      Javad Charostad, Akram Astani, Hossein Goudarzi, Ebrahim Faghihloo
      Reviews in Medical Virology.2019;[Epub]     CrossRef
    • Identification and characterization of an alternative cancer-derived PD-L1 splice variant
      Nadia B. Hassounah, Venkat S. Malladi, Yi Huang, Samuel S. Freeman, Ellen M. Beauchamp, Shohei Koyama, Nicholas Souders, Sunil Martin, Glenn Dranoff, Kwok-Kin Wong, Chandra S. Pedamallu, Peter S. Hammerman, Esra A. Akbay
      Cancer Immunology, Immunotherapy.2019; 68(3): 407.     CrossRef
    • What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?
      Liam Hayman, Wajeeh Raza Chaudhry, Victor V. Revin, Nikolai Zhelev, Jean-Christophe Bourdon
      Expert Review of Molecular Diagnostics.2019; 19(2): 149.     CrossRef
    • Transforming properties of ovine papillomaviruses E6 and E7 oncogenes
      Gessica Tore, Gian Mario Dore, Carla Cacciotto, Rosita Accardi, Antonio G. Anfossi, Luisa Bogliolo, Marco Pittau, Salvatore Pirino, Tiziana Cubeddu, Massimo Tommasino, Alberto Alberti
      Veterinary Microbiology.2019; 230: 14.     CrossRef
    • Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins
      Niloofar Khodabandehlou, Shayan Mostafaei, Ashkan Etemadi, Amir Ghasemi, Mehrdad Payandeh, Shima Hadifar, Amir Hossein Norooznezhad, Anoshirvan Kazemnejad, Mohsen Moghoofei
      BMC Cancer.2019;[Epub]     CrossRef
    • HPVE6/E7,hTERT, andKi67mRNA RT-qPCR Assay for Detecting High-Grade Cervical Lesion with Microscope Slides
      Geehyuk Kim, Jemberu Taye, Kwangmin Yu, Sunyoung Park, Jungho Kim, Sunghyun Kim, Dongsup Lee, Hye-young Wang, Kwang Hwa Park, Hyeyoung Lee
      Analytical Cellular Pathology.2019; 2019: 1.     CrossRef
    • A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer
      Ledan Wang, Wangqi Du, Shanli Zhu, Pengfei Jiang, Lifang Zhang
      Applied Microbiology and Biotechnology.2019; 103(7): 3049.     CrossRef
    • HOXC6 promotes cervical cancer progression via regulation of Bcl‐2
      Yongsheng Wang, Cong Wang, Na Liu, Jun Hou, Wenjing Xiao, Hui Wang
      The FASEB Journal.2019; 33(3): 3901.     CrossRef
    • Meta‐analysis of the accuracy of p16 or p16/Ki‐67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology
      Eliana Peeters, Nicolas Wentzensen, Christine Bergeron, Marc Arbyn
      Cancer Cytopathology.2019; 127(3): 169.     CrossRef
    • Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells
      Jamie A. Barr, Karen E. Hayes, Tayvia Brownmiller, Abby D. Harold, Rajaganapathi Jagannathan, Paul R. Lockman, Saleem Khan, Ivan Martinez
      Scientific Reports.2019;[Epub]     CrossRef
    • Pongapin and Karanjin, furanoflavanoids of Pongamia pinnata, induce G2/M arrest and apoptosis in cervical cancer cells by differential reactive oxygen species modulation, DNA damage, and nuclear factor kappa‐light‐chain‐enhancer of activated B cell signal
      Rituparna Roy, Debolina Pal, Subhayan Sur, Suvra Mandal, Prosenjit Saha, Chinmay Kumar Panda
      Phytotherapy Research.2019; 33(4): 1084.     CrossRef
    • Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model
      Jiantai Qiu, Donia Alson, Ta-Hsien Lee, Ching-Chou Tsai, Ting-Wei Yu, Yu-Sing Chen, Ya-Fang Cheng, Chu-Chi Lin, Scott Schuyler
      Cancers.2019; 11(3): 368.     CrossRef
    • Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer
      Rashmi Deshpande, Prerna Raina, Kavita Shinde, Prakash Mansara, Manjiri Karandikar, Ruchika Kaul-Ghanekar
      Prostaglandins & Other Lipid Mediators.2019; 143: 106332.     CrossRef
    • The free energy landscape of the oncogene protein E7 of human papillomavirus type 16 reveals a complex interplay between ordered and disordered regions
      Predrag Kukic, Giuseppe Mattia Lo Piccolo, Marcela O. Nogueira, Dmitri I. Svergun, Michele Vendruscolo, Isabella C. Felli, Roberta Pierattelli
      Scientific Reports.2019;[Epub]     CrossRef
    • Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome
      Xiaofan Lu, Liyun Jiang, Liya Zhang, Yue Zhu, Wenjun Hu, Jiashuo Wang, Xinjia Ruan, Zhengbao Xu, Xiaowei Meng, Jun Gao, Xiaoping Su, Fangrong Yan
      Neoplasia.2019; 21(6): 591.     CrossRef
    • How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac Insufficiency
      Tim Breitenbach, Kristina Lorenz, Thomas Dandekar
      International Journal of Molecular Sciences.2019; 20(9): 2179.     CrossRef
    • Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis
      Kaushiki Chatterjee, Sumit Mukherjee, Jonathan Vanmanen, Probal Banerjee, Jimmie E. Fata
      Frontiers in Oncology.2019;[Epub]     CrossRef
    • Human papilloma virus DNA-biomarker analysis for cervical cancer: Signal enhancement by gold nanoparticle-coupled tetravalent streptavidin-biotin strategy
      Qingfeng Lv, Yongmei Wang, Cuijin Su, Thangavel Lakshmipriya, Subash C.B. Gopinath, Kannaiyan Pandian, Veeradasan Perumal, Ying Liu
      International Journal of Biological Macromolecules.2019; 134: 354.     CrossRef
    • RNA-seq analysis in equine papillomavirus type 2-positive carcinomas identifies affected pathways and potential cancer markers as well as viral gene expression and splicing events
      Anna Sophie Ramsauer, Jakub Kubacki, Claude Favrot, Mathias Ackermann, Cornel Fraefel, Kurt Tobler
      Journal of General Virology .2019; 100(6): 985.     CrossRef
    • Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma
      Kwanghee Ahn, Sojung Kweon, Dae Woon Kim, Hojung Lee
      Obstetrics & Gynecology Science.2019; 62(3): 157.     CrossRef
    • Delivery of microRNAs by Extracellular Vesicles in Viral Infections: Could the News be Packaged?
      Fabio Seiti Yamada Yoshikawa, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato, Luanda Mara da Silva Oliveira
      Cells.2019; 8(6): 611.     CrossRef
    • The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer
      Jiao Chen, Yan Deng, Liangfei Ao, Yi Song, Yan Xu, Chi Chiu Wang, Kwong Wai Choy, Kwok Hung Tony Chung, Quan Du, Yi Sui, Tao Yang, Jing Yang, Hu Li, Chang Zou, Tao Tang
      Cancer Letters.2019; 460: 75.     CrossRef
    • A unique insert in the genomes of high-risk human papillomaviruses with a predicted dual role in conferring oncogenic risk
      Noam Auslander, Yuri I. Wolf, Svetlana A. Shabalina, Eugene V. Koonin
      F1000Research.2019; 8: 1000.     CrossRef
    • Papillomavirus DNA not detected in canine lobular orbital adenoma and normal conjunctival tissue
      Elizabeth A. F. Schaefer, Shirley Chu, Jacqueline W. Pearce, Jeffrey N. Bryan, Brian K. Flesner
      BMC Veterinary Research.2019;[Epub]     CrossRef
    • Phenotype-based discovery of a HeLa-specific cytotoxic molecule that downregulates HPV-mediated signaling pathwaysviaoxidative damage
      Sanghee Lee, Wansang Cho, Sungyoul Hong, Sihyeong Yi, Heejun Kim, Soo Yeon Baek, Hankum Park, Jinjoo Jung, Young Kee Shin, Seung Bum Park
      Organic & Biomolecular Chemistry.2019; 17(31): 7388.     CrossRef
    • High Incidence of Human Papillomavirus Types 16 and 18 in Cervical Carcinoma Patients in a Tertiary Care Unit, Jabalpur, MP, India
      Shyamji Rawat, Sulekha Yadav, Pranjil Mandloi, Chinkal Panihar, P. V. Barde
      Indian Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
    • Advances in technologies for cervical cancer detection in low-resource settings
      Kathryn A. Kundrod, Chelsey A. Smith, Brady Hunt, Richard A. Schwarz, Kathleen Schmeler, Rebecca Richards-Kortum
      Expert Review of Molecular Diagnostics.2019; 19(8): 695.     CrossRef
    • Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
      Chenhao Zhou, Zewen Kelvin Tuong, Ian Hector Frazer
      Frontiers in Oncology.2019;[Epub]     CrossRef
    • Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery
      Srikanth Kolluru, Rosemary Momoh, Lydia Lin, Jayapal Reddy Mallareddy, John L. Krstenansky
      BMC Molecular and Cell Biology.2019;[Epub]     CrossRef
    • The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1
      Jennifer L. McCann, Madeline M. Klein, Evelyn M. Leland, Emily K. Law, William L. Brown, Daniel J. Salamango, Reuben S. Harris
      Journal of Biological Chemistry.2019; 294(32): 12099.     CrossRef
    • LncRNA SRA1 is down-regulated in HPV-negative cervical squamous cell carcinoma and regulates cancer cell behaviors
      Yunyong Liu, Mengdan Li, Huihui Yu, Haozhe Piao
      Bioscience Reports.2019;[Epub]     CrossRef
    • Diagnosis and management of vulvar cancer: A review
      Andrea Tan, Amy K. Bieber, Jennifer A. Stein, Miriam K. Pomeranz
      Journal of the American Academy of Dermatology.2019; 81(6): 1387.     CrossRef
    • Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter
      Nobumaru Hirao, Takashi Iwata, Kohsei Tanaka, Hiroshi Nishio, Masaru Nakamura, Tohru Morisada, Kenji Morii, Natsuki Maruyama, Yuki Katoh, Tomonori Yaguchi, Shigeki Ohta, Iwao Kukimoto, Daisuke Aoki, Yutaka Kawakami
      Gynecologic Oncology.2019; 155(2): 340.     CrossRef
    • Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine
      Sedigheh Taghinezhad-S, Amir Hossein Mohseni, Hossein Keyvani, Mohammad Reza Razavi
      Molecular Therapy - Methods & Clinical Development.2019; 15: 40.     CrossRef
    • Cloning and expression of the L1 immunogenic protein of human papillomavirus genotype 16 by using Lactobacillus expression system
      Masumeh Haj Hodaei, Rudabeh Behzadi Anduhjerdi, Jalil Fallah Mehrabadi, Davoud Esmaeili
      Gene Reports.2019; 17: 100521.     CrossRef
    • Relationship between p16 expression and prognosis in different anatomic subsites of OSCC
      Yanhong Ni, Xiaoxin Zhang, Yunxia Wan, Kai Dun Tang, Yin Xiao, Yue Jing, Yuxian Song, Xiaofeng Huang, Chamindie Punyadeera, Qingang Hu
      Cancer Biomarkers.2019; 26(3): 375.     CrossRef
    • A unique insert in the genomes of high-risk human papillomaviruses with a predicted dual role in conferring oncogenic risk
      Noam Auslander, Yuri I. Wolf, Svetlana A. Shabalina, Eugene V. Koonin
      F1000Research.2019; 8: 1000.     CrossRef
    • A Current Update on Human Papillomavirus-Associated Head and Neck Cancers
      Ebenezer Tumban
      Viruses.2019; 11(10): 922.     CrossRef
    • Current Perspectives in Human Papilloma Virus: Where We are and What We Need?
      B.S Anjali Devi, Venugopal Reddy Bovilla, SubbaRao V. Madhunapantula
      Biomedical and Pharmacology Journal.2019; 12(04): 1683.     CrossRef
    • Plant viral and bacteriophage delivery of nucleic acid therapeutics
      Patricia Lam, Nicole F. Steinmetz
      WIREs Nanomedicine and Nanobiotechnology.2018;[Epub]     CrossRef
    • Prevalence of human papillomavirus in benign and malignant laryngeal lesions in Egyptian patients: Cross‐sectional study
      P. Milad, H. Kassamy, A. Askoura, S. Abuelela, R. Salem, D. Ragab
      Clinical Otolaryngology.2018; 43(1): 312.     CrossRef
    • Human papillomavirus E7 induces p63 expression to modulate DNA damage response
      Sahar Eldakhakhny, Qing Zhou, Emma J. Crosbie, Berna S. Sayan
      Cell Death & Disease.2018;[Epub]     CrossRef
    • ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer
      Nam-phuong D Nguyen, Viraj Deshpande, Jens Luebeck, Paul S Mischel, Vineet Bafna
      Nucleic Acids Research.2018; 46(7): 3309.     CrossRef
    • Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells
      Kaushiki Chatterjee, Dina AlSharif, Christina Mazza, Palwasha Syar, Mohamed Al Sharif, Jimmie E. Fata
      Nutrients.2018; 10(2): 243.     CrossRef
    • Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer
      Yingji Jin, Seung Cheol Kim, Hyoung Jin Kim, Woong Ju, Yun Hwan Kim, Hong-Jin Kim
      Archives of Pharmacal Research.2018; 41(4): 438.     CrossRef
    • ARFHPV E7 oncogene, lncRNA HOTAIR, miR‐331‐3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer
      Min Zhang, Yinghui Song, Furui Zhai
      Journal of Cellular Biochemistry.2018; 119(6): 4397.     CrossRef
    • Lupeol induces S-phase arrest and mitochondria-mediated apoptosis in cervical cancer cells
      Nupoor Prasad, Akash Sabarwal, Umesh C S Yadav, Rana P Singh
      Journal of Biosciences.2018; 43(2): 249.     CrossRef
    • Deregulated TNF-Alpha Levels Along with HPV Genotype 16 Infection Are Associated with Pathogenesis of Cervical Neoplasia in Northeast Indian Patients
      Chandana Ray Das, Diptika Tiwari, Anita Dongre, Mohammad Aasif Khan, Syed Akhtar Husain, Anirudha Sarma, Sujoy Bose, Purabi Deka Bose
      Viral Immunology.2018; 31(4): 282.     CrossRef
    • Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens
      Jonathan S. LeCureux, Gregg A. Dean, Christopher J. Papasian
      mSphere.2018;[Epub]     CrossRef
    • SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer‐related phenotypes
      Viviana E. Hermosilla, Ginessa Salgado, Elizabeth Riffo, David Escobar, Matías I. Hepp, Carlos Farkas, Mario Galindo, Violeta Morín, María A. García‐Robles, Ariel F. Castro, Roxana Pincheira
      Molecular Oncology.2018; 12(7): 1026.     CrossRef
    • The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells
      Hamidreza Javadi, Abbas Sahebghadam Lotfi, Saman Hosseinkhani, Hossein Mehrani, Jafar Amani, Zahra Soheila Soheili, Zahra Hojati, Mehdi Kamali
      Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup2): 727.     CrossRef
    • A Cu2+ complex induces the aggregation of human papillomavirus oncoprotein E6 and stabilizes p53
      Amit Kumar, Lars T. Kuhn, Jochen Balbach
      The FEBS Journal.2018; 285(16): 3013.     CrossRef
    • The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses
      Elena Wüstenhagen, Fatima Boukhallouk, Inka Negwer, Krishnaraj Rajalingam, Frank Stubenrauch, Luise Florin
      Oncogene.2018; 37(48): 6275.     CrossRef
    • Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
      Z. Ping Lin, Yong-Lian Zhu, Elena S. Ratner
      Frontiers in Oncology.2018;[Epub]     CrossRef
    • Development and validation of a multiplex reverse transcript real-time PCR for E6/E7 mRNA detection of high-risk human papillomavirus
      Caixia Pan, Jing Zhou, Jiangfeng Lyu, Xuyi Ren
      Journal of Medical Microbiology.2018; 67(10): 1509.     CrossRef
    • High-affinity binding with specific peptides endows EuW10a good luminescence probe for HPV E6 detection
      Yuxue Liu, Xinxin Yuan, Weixian Wang, Yuqing Wu, Lixin Wu
      New Journal of Chemistry.2018; 42(21): 17339.     CrossRef
    • Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response
      Diletta Francesca Squarzanti, Rita Sorrentino, Manuela Miriam Landini, Andrea Chiesa, Sabrina Pinato, Francesca Rocchio, Martina Mattii, Lorenza Penengo, Barbara Azzimonti
      Virology Journal.2018;[Epub]     CrossRef
    • Do Human Papilloma Viruses Play a Role in the Genesis of Cutaneous Malignancies?
      Mohamed JEMF Mabruk
      Journal of Dermatology & Cosmetology.2018;[Epub]     CrossRef
    • Nicotinic acetylcholine receptor gene polymorphism is not associated with tobacco-related oral squamous cell carcinoma
      Deepa Rajesh, SM Azeem Mohiyuddin, Sharath Balakrishna, AV Moideen Kutty
      Indian Journal of Cancer.2018; 55(4): 399.     CrossRef
    • Immune Checkpoint Inhibition in the Treatment of Gynecologic Cancer
      Kristen Anderson, Ramez N. Eskander
      Current Obstetrics and Gynecology Reports.2018; 7(1): 6.     CrossRef
    • Identification of fatal outcome in a childhood nasopharyngeal carcinoma patient by protein expression profiling
      Mohamed Saeed, Rolf Mertens, Rupert Handgretinger, Thomas Efferth
      International Journal of Oncology.2018;[Epub]     CrossRef
    • Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16+ Oral Tumors and Immunologic Control
      Yi-Hsin Lin, Ming-Chieh Yang, Ssu-Hsueh Tseng, Rosie Jiang, Andrew Yang, Emily Farmer, Shiwen Peng, Talia Henkle, Yung-Nien Chang, Chien-Fu Hung, T.-C. Wu
      Cancer Immunology Research.2018; 6(3): 305.     CrossRef
    • Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers
      Jialing Zhang, Tony Chen, Xinping Yang, Hui Cheng, Stephan S. Späth, Paul E. Clavijo, Jianhong Chen, Christopher Silvin, Natalia Issaeva, Xiulan Su, Wendell G. Yarbrough, Christina M. Annunziata, Zhong Chen, Carter Van Waes
      Cancer Research.2018; 78(16): 4613.     CrossRef
    • Relevant Allelic Frequency of Gene Polymorphism and Genetic Predisposition of Human Papillomavirus in Patients with Cervical Cancer
      Nikta Sajjadi, Reza Mirnejad, Malike Sharif, Vahhab Piranfar, Davood Zaeifi
      Modern Medical Laboratory Journal.2018; 1(2): 50.     CrossRef
    • Epidemiology and biology of cutaneous human papillomavirus
      Emily M Nunes, Valéria Talpe-Nunes, Laura Sichero
      Clinics.2018; 73: e489s.     CrossRef
    • Genome characterization of a bovine papillomavirus type 5 from cattle in the Amazon region, Brazil
      Flavio R. C. da Silva, Cíntia Daudt, Samuel P. Cibulski, Matheus N. Weber, Ana Paula M. Varela, Fabiana Q. Mayer, Paulo M. Roehe, Cláudio W. Canal
      Virus Genes.2017; 53(1): 130.     CrossRef
    • Exploring the potential of genome editing CRISPR-Cas9 technology
      Vijai Singh, Darren Braddick, Pawan Kumar Dhar
      Gene.2017; 599: 1.     CrossRef
    • Two-step chromatographic purification of glutathione S-transferase-tagged human papillomavirus type 16 E6 protein and its application for serology
      Mei Ling Xu, Seung Cheol Kim, Hyoung Jin Kim, Woong Ju, Yun Hwan Kim, Hong-Jin Kim
      Protein Expression and Purification.2017; 132: 19.     CrossRef
    • Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
      Christian Bressy, Eric Hastie, Valery Z. Grdzelishvili
      Molecular Therapy - Oncolytics.2017; 5: 20.     CrossRef
    • MiR-23b controls ALDH1A1 expression in cervical cancer stem cells
      Weiwen Wang, Yang Li, Na Liu, Yu Gao, Long Li
      BMC Cancer.2017;[Epub]     CrossRef
    • Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit
      Daniel Henry Marks, Rozario Thomas, Yvette Chin, Riddhi Shah, Christine Khoo, Robert Benezra
      Cell Reports.2017; 19(9): 1832.     CrossRef
    • Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications
      Anjelica Hodgson, Yutaka Amemiya, Arun Seth, Matthew Cesari, Bojana Djordjevic, Carlos Parra-Herran
      Modern Pathology.2017; 30(11): 1633.     CrossRef
    • Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
      Andrew Yang, Shiwen Peng, Emily Farmer, Qi Zeng, Max A. Cheng, Xiaowu Pang, T. -C. Wu, Chien-Fu Hung
      Cell & Bioscience.2017;[Epub]     CrossRef
    • Virus like particles as a platform for cancer vaccine development
      Hui Kian Ong, Wen Siang Tan, Kok Lian Ho
      PeerJ.2017; 5: e4053.     CrossRef
    • Expression of cell cycle-related proteins in oropharyngeal squamous cell carcinoma based on human papilloma virus status
      Koudai Tsuchida, Tamotsu Sugai, Noriyuki Uesugi, Kazuyuki Ishida, Kazuto Matsuura, Ikuro Sato, Kiyoto Shiga, Hiroaki Sato
      Oncology Reports.2017; 38(2): 908.     CrossRef
    • Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection
      Vjosa A. Zejnullahu, Valon A. Zejnullahu, Slavica Josifovska, Nikola Vukovik, Kiril Pakovski, Sasho Panov
      PRILOZI.2017; 38(3): 143.     CrossRef
    • TAT‑mediated si‑hWAPL inhibits the invasion and metastasis of cervical cancer stem cells
      Pijun Gong, Chunyan Hu, Xi Zhou, Renxiao Wang, Zhao Duan
      Experimental and Therapeutic Medicine.2017;[Epub]     CrossRef
    • Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer (Review)
      Prakriti Sen, Pooja Ganguly, Niladri Ganguly
      Oncology Letters.2017;[Epub]     CrossRef
    • Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective
      Balazs B. Lörincz, Nathan Jowett, Rainald Knecht
      Head & Neck.2016;[Epub]     CrossRef
    • The Role of p53 Gene in Cervical Carcinogenesis
      Garima, Sulekha Pandey, L. K. Pandey, A. K. Saxena, Nidhi Patel
      The Journal of Obstetrics and Gynecology of India.2016; 66(S1): 383.     CrossRef
    • Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
      Samatha Bhat, Shama Prasada Kabekkodu, Ashish Noronha, Kapaettu Satyamoorthy
      Biochimie.2016; 121: 298.     CrossRef
    • Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma
      Ming Yann Lim, Kristina R. Dahlstrom, Erich M. Sturgis, Guojun Li
      Head & Neck.2016; 38(8): 1139.     CrossRef
    • A Giant Vulvar Mass: A Case Study of Cellular Angiofibroma
      Ümit Aydın, Hasan Terzi, Ünal Turkay, Ahmet Tuğrul Eruyar, Ahmet Kale
      Case Reports in Obstetrics and Gynecology.2016; 2016: 1.     CrossRef
    • Aptima HR-HPV testing from Diff-Quick-stained fine-needle aspiration smears of oropharyngeal squamous cell carcinoma
      Min Han, Cory T. Bernadt, Benjamin Murray, Steven M. Johnson, Jalal B. Jalaly, Telly Garcia, Laura J. Adhikari
      Journal of the American Society of Cytopathology.2016; 5(4): 221.     CrossRef
    • Loss of histone variant macroH2A2 expression associates with progression of anal neoplasm
      Wan-Hsiang Hu, Katsumi Miyai, Judith C Sporn, Linda Luo, Jean Y J Wang, Bard Cosman, Sonia Ramamoorthy
      Journal of Clinical Pathology.2016; 69(7): 627.     CrossRef
    • Targeting HPV‐infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine
      Rachel M. Levine, Christina V. Dinh, Michael A. Harris, Efrosini Kokkoli
      Bioengineering & Translational Medicine.2016; 1(2): 168.     CrossRef
    • New Strategies for Multimodality Therapy in Treating Locally Advanced Cervix Cancer
      Jonathan Verma, Bradley J. Monk, Aaron H. Wolfson
      Seminars in Radiation Oncology.2016; 26(4): 344.     CrossRef
    • A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia
      Vânia Sammartino Mariano, Adriana Tarlá Lorenzi, Cristovam Scapulatempo-Neto, Maíra Degiovani Stein, Julio Cesar Possati Resende, Márcio Antoniazzi, Luisa Lina Villa, José Eduardo Levi, Adhemar Longatto-Filho, José Humberto Tavares Guerreiro Fregnani, Kal
      PLOS ONE.2016; 11(10): e0164892.     CrossRef
    • Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis
      Asaha Fujimoto, Kei Kawana, Ayumi Taguchi, Katsuyuki Adachi, Masakazu Sato, Hiroe Nakamura, Juri Ogishima, Mitsuyo Yoshida, Tomoko Inoue, Haruka Nishida, Kensuke Tomio, Aki Yamashita, Yoko Matsumoto, Takahide Arimoto, Osamu Wada-Hiraike, Katsutoshi Oda, T
      Oncotarget.2016; 7(32): 51854.     CrossRef
    • The potential of plants for the production and delivery of human papillomavirus vaccines
      Sergio Rosales-Mendoza, Dania O Govea-Alonso
      Expert Review of Vaccines.2015; 14(7): 1031.     CrossRef
    • NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome
      P Chandrani, V Kulkarni, P Iyer, P Upadhyay, R Chaubal, P Das, R Mulherkar, R Singh, A Dutt
      British Journal of Cancer.2015; 112(12): 1958.     CrossRef
    • An overview of new biomolecular pathways in pathogen-related cancers
      Maria Lina Tornesello, Luigi Buonaguro, Franco M Buonaguro
      Future Oncology.2015; 11(11): 1625.     CrossRef
    • Cellular angiofibroma in women: a review of the literature
      Vincenzo Dario Mandato, Susanna Santagni, Alberto Cavazza, Lorenzo Aguzzoli, Martino Abrate, Giovanni Battista La Sala
      Diagnostic Pathology.2015;[Epub]     CrossRef
    • Human papillomavirus and host genetic polymorphisms in carcinogenesis: A systematic review and meta-analysis
      Steven Habbous, Vincent Pang, Wei Xu, Eitan Amir, Geoffrey Liu
      Journal of Clinical Virology.2014; 61(2): 220.     CrossRef
    • Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer
      Matthew P Morrow, Jian Yan, Niranjan Y Sardesai
      Expert Review of Vaccines.2013; 12(3): 271.     CrossRef
    • ProExC is a novel marker for distinguishing between primary endometrial and endocervical adenocarcinomas
      Ghada E. Esheba
      Journal of the Egyptian National Cancer Institute.2013; 25(2): 87.     CrossRef
    • Canine distemper virus induces apoptosis in cervical tumor derived cell lines
      Helen L Del Puerto, Almir S Martins, Amy Milsted, Elaine M Souza-Fagundes, Gissandra F Braz, Barbara Hissa, Luciana O Andrade, Fabiana Alves, Daniela S Rajão, Rômulo C Leite, Anilton C Vasconcelos
      Virology Journal.2011;[Epub]     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis
      Cancer Res Treat. 2005;37(6):319-324.   Published online December 31, 2005
      Close
    • XML DownloadXML Download
    The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis
    Image
    Fig. 1 HPV E6 and E7 binding to P53, with Rb interfering with the normal functions of the tumor suppressors.
    The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis

    Cellular binding partners for HPV E6

    Cellular binding partners for HPV E7

    Table 1 Cellular binding partners for HPV E6

    Table 2 Cellular binding partners for HPV E7


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP